PASITHEA THERAPEUTICS CORP. Stock Repurchase Program, Number of Shares Authorized to be Repurchased
PASITHEA THERAPEUTICS CORP. (KTTA) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 20.82 million shares as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2024-03-29
- 2023-09-30: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 20.82M shares.
- 2023-09-14: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 266.17K shares; Stock Repurchase Program, Number of Shares Authorized to be Repurchased as first filed 3.73M shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased | Stock Repurchase Program, Number of Shares Authorized to be Repurchased as first filed |
|---|---|---|
| 2023-09-30 | 20.82M shares 10-Q · filed 2023-11-13 | |
| 2023-09-14 | 266.17K shares 10-K · filed 2024-03-29 | 3.73M shares 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |